Trials / Completed
CompletedNCT01820728
A Phase III Clinical Study to Compare the Efficacy and Safety of DA-3801 and That of Gonal-F®
A Phase III Clinical Study for the Comparison Evaluation of DA-3801 and Gonal-F® in Infertile Female Patients With Chronic Anovulation Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- Female
- Age
- 20 Years – 38 Years
- Healthy volunteers
- Not accepted
Summary
open label, active-controlled, randomized, parallel group, comparative study.
Detailed description
This is a phase III comparative study to evaluate the effectiveness and safety of DA-3801 in treatment of the patients with WHO Group II anovulatory infertility failing to clomiphene citrate treatment. The study is conducted with following methods: open label, active-controlled, randomized, parallel group, comparative.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-3801 Injection | |
| DRUG | Gonal-F® |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2013-03-29
- Last updated
- 2021-04-15
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01820728. Inclusion in this directory is not an endorsement.